Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Primary Care Policy topic
No spam. Unsubscribe anytime.
Wyoming Medical Society urges investment in primary care and flags consolidation costs
Summary
Sheila Bush of the Wyoming Medical Society told the task force that boosting primary care access can lower total costs over time and that physician employment and consolidation have driven some price increases when services move from clinics to hospital outpatient settings.
Sheila Bush, representing the Wyoming Medical Society, told the Health Insurance Affordability Task Force that access to primary care is foundational to lowering long‑term costs.
Bush summarized national and state data showing that greater primary‑care capacity is associated with lower mortality and lower overall health spending. She said the U.S. currently spends a relatively small share of total health spending on primary care compared with other OECD nations and that increasing primary‑care investment is one lever that can reduce expensive downstream outcomes — for example, early diabetes management that can prevent amputations and long hospital stays.
Bush also discussed EMTALA (the Emergency Medical Treatment and Labor Act) as an unfunded federal requirement that effectively guarantees emergency care and affects hospitals’ cost structures. On consolidation, she cited studies finding that shifting office visits from independent clinics into hospital outpatient departments increased Medicare spending and beneficiary cost sharing; she urged the task force to study whether consolidation has materially affected Wyoming costs.
Bush recommended that the committee consider state‑specific data and careful, Wyoming‑tailored analysis before advancing measures. The medical society offered to partner on data requests and to bring additional materials to the next meeting.
The committee thanked the medical society and asked staff to collect state‑specific measures of consolidation and primary‑care capacity as part of the follow‑up materials.
